Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Other Accumulated Expenses: 2018-2025

Historic Other Accumulated Expenses for Verastem (VSTM) over the last 8 years, with Sep 2025 value amounting to $2.0 million.

  • Verastem's Other Accumulated Expenses rose 42.44% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 42.44%. This contributed to the annual value of $1.4 million for FY2024, which is N/A change from last year.
  • Per Verastem's latest filing, its Other Accumulated Expenses stood at $2.0 million for Q3 2025, which was up 13.57% from $1.8 million recorded in Q2 2025.
  • Verastem's 5-year Other Accumulated Expenses high stood at $12.6 million for Q2 2022, and its period low was $996,000 during Q4 2022.
  • In the last 3 years, Verastem's Other Accumulated Expenses had a median value of $1.7 million in 2025 and averaged $3.6 million.
  • As far as peak fluctuations go, Verastem's Other Accumulated Expenses spiked by 5,553.85% in 2021, and later crashed by 89.30% in 2022.
  • Verastem's Other Accumulated Expenses (Quarterly) stood at $9.3 million in 2021, then slumped by 89.30% to $996,000 in 2022, then climbed by 10.92% to $9.1 million in 2023, then slumped by 84.36% to $1.4 million in 2024, then soared by 42.44% to $2.0 million in 2025.
  • Its Other Accumulated Expenses stands at $2.0 million for Q3 2025, versus $1.8 million for Q2 2025 and $1.7 million for Q1 2025.